- Filed
- May 12, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 76.31M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 76.21M sh |
| Capex | Q1 2025 · Mar 31, 2025 | $13.62M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | $1.13M |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $2.42B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $2.42B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $15M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $15M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $369.68M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $387.25M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $1.13B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $1.25B |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$6.75B |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$6.6B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $491.79M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $514.99M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $1.45B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $1.48B |
| Total Assets | Q1 2025 · Mar 31, 2025 | $4.19B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.35B |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | −$1.69 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | −$1.69 |
| Sga Expense | Q1 2025 · Mar 31, 2025 | $149.04M |
| Net Income | Q1 2025 · Mar 31, 2025 | −$128.63M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$154.23M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2025 | $295.4M |
| Revenue | Q1 2025 · Mar 31, 2025 | $392.83M |